A Non Interventional Study With Doce Onkovis (Docetaxel) Utilized for the Treatment of Cancer

Onkovis

Status: Completed

Conditions: Carcinoma

Study type: Observational

Funder types: Industry

Identifiers

NCT01614002

ONKODOC 01

Details and patient eligibility

About

The main purpose of this observational study with Docetaxel is to determine the number of treatment cycles and the quantity of Doce onkovis needed therefore under the special circumstance of ambulant chemotherapy.

onkovis aims an economical utilization of the chemotherapeutics.The provision with adapted packaging sizes as to decrease the excess quantity to be discarded follows also this objective.

Secondary objectives are the evaluation of the safety and tolerability of Doce onkovis. To this purpose data regarding co medications and adverse events are also collected.

Enrollment: 371 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Indication for Docetaxel according to the SmPC and treating physician

Exclusion criteria

• according to the Docetaxel SmPC

Trial design

371 participants in 1 patient group

carcinoma, Doce onkovis (Docetaxel)

Description:

treatment in mono- or combination therapy with Docetaxel of breast cancer, non-small cell lung cancer, prostata carcinoma, adenocarcinoma of the stomach and advanced squamous cell carcinoma of the head/neck region.